As CMS3 colon tumors are characterized by mutated KRAS and since LKB1 mutation also occurs frequently in colon cancer [58], this mechanism could be a relevant immune escape mechanisms in this context as well. The gene discussed is KRAS; the disease is colonic neoplasm.